
Trade tensions, not BRICS, are the bigger threat to global stability: Geoff Dennis
Synopsis Geoff Dennis, an Independent EM Commentator, dismisses the notion of BRICS posing a currency threat to the US, despite China's desire for a stronger RMB. While some de-dollarization exists, Dennis believes Trump's perception of any overseas collaboration as anti-American is a key factor. "The Chinese are desperate for the RMB to play a bigger role. But frankly, I do not see what the BRICS are doing or what they are trying to do represents a currency related threat to the US whatsoever," says Geoff Dennis, Independent EM Commentator.
ADVERTISEMENT When we speak about the idea of de-dollarisation and we have seen countries like India for instance, we have publicly stated that we are not going to move away from the dollar and de-dollarisation is not a policy that India essentially is looking at. But is there an immediate threat to the United States or to the G7 group of nations from BRICS because Donald Trump is making these comments over and over again. So, do you anticipate an immediate threat A) to the dollar and, of course, to US' hegemony?
Geoff Dennis: I do not believe so. This is an issue which has allegedly impacted markets for the best part of 50 years. I am an old guy, I have been around a long time and we were talking about potentially the Deutsche Mark replacing the US dollar as a key reserve currency or the key reserve currency in the late 70s and it has just never happened. Now, right now there is some evidence, of course, that central banks are diversifying out of the dollar. The Chinese are desperate for the RMB to play a bigger role. But frankly, I do not see what the BRICS are doing or what they are trying to do represents a currency related threat to the US whatsoever. I just do not get it frankly. And so, there is some de-dollarisation going on for sure, but I am not sure it is major and I am not sure it is involving the BRICS. In fact, frankly, my own interpretation of all of this is that anything that anybody does overseas, especially if countries get together is almost automatically defined by Trump is anti-America and there is nothing about what the BRICS are doing that is really seriously anti-America and this all boils down at the end of the day to the fact that I just think de-dollarisation is not something that is going to go far in the world even if the dollar's really truly dominant position has pulled back a little bit over the last few years.
Given the fact that the reform Bretton Woods and reduce dollar reliance in fact is not new, but is BRICS gaining structural momentum this time in your opinion?
Geoff Dennis: It is gaining structural momentum in the sense that you have got a number of other large countries as everybody knows joining BRICS that over and above the original BRICS which was defined by my old friend Jim O'Neill in 2001 which was, of course, just Brazil, Russia, India, China. There are some very important countries that have joined. But still I am not sure exactly what a BRICS summit achieves.
Yes, they say all the right things about we support free trade. We condemn tariffs whatever it might be or non-tariff barriers, but as to how much power this group actually can demonstrate currently in the world economy especially against a US president who frankly is a bully to everybody who seems to threaten in some vague way the US dominant position of the world economy. So, I think it does not sort of matter to me within reason what the BRICS does at this point, whether it gets bigger, whether it gets smaller, whether a lot of presidents and heads of state come to the conferences or not.
ADVERTISEMENT At the end of the day I do not think it has a lot of power except to say all the right things about trade policy and meanwhile President Trump is rampaging around the global economy like a bull in a China shop and the BRICS will become part of that unfortunately and yet, I do not know how the BRICS particularly fights back and I certainly do not see it as I said earlier being something that is going to turn into a brics-led currency, whatever reserve currency that is going to replace the dollar. The problem here is Trump's tariff policy and it is as simple as that frankly.
(You can now subscribe to our ETMarkets WhatsApp channel)
BRICSGeoff Denniscurrency threat to USRMBUS hegemony Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share
Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained
Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms
Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips
L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first?
Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more
SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders
API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading
Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains
Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains
NEXT STORY
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


News18
13 minutes ago
- News18
'Where Did You Learn That?': Trump Trolled For Praising Liberian President's English
Donald Trump faced backlash after praising Liberian President Boakai for speaking "such good English". US President Donald Trump faced backlash on social media after he praised Liberian President Joseph Boakai for speaking 'such good English" during a meeting with African leaders at the White House- seemingly unaware that English is Liberia's official language. 'Where did you learn to speak so beautifully?" Donald Trump asked Joseph Boakai, adding, 'Where were you educated? Where? In Liberia? Well, that's very interesting. It's beautiful English. I have people at this table who can't speak nearly as well." Trump to the President of Liberia: 'Such good English. Where did you learn to speak so beautifully?"English is the official language of Liberia… — The Bulwark (@BulwarkOnline) July 9, 2025 Joseph Boakai, who was speaking at the event, made no visible reaction to Donald Trump's comments but the clip quickly went viral, triggering a wave of criticism on social media. 'Trump just praised the leader of Liberia for his English. 'Where did you learn to speak so beautifully?' FACT: English is the official language of Liberia. NATIONAL EMBARRASSMENT," wrote influencer Brian Krassenstein on X (formerly Twitter). 'Trump to Liberian President: Such beautiful English, where did you learn to speak English? English is the official language of Liberia. This is embarrassing," another user posted. 'Trump patronizingly asks the President of Liberia how he learned to speak English so beautifully. Trump, of course, has no idea that English is the official language of Liberia," added another. English has been Liberia's national language since the country's founding in the 19th century by freed American slaves. Its capital, Monrovia, is named after US President James Monroe, and the country's constitution was modeled after the US system. This isn't the first time Donald Trump's comments on African nations have sparked controversy. In 2018, during his first term, he referred to Haiti and several African countries as 'shithole nations" during a closed-door meeting. Get breaking news, in-depth analysis, and expert perspectives on everything from geopolitics to diplomacy and global trends. Stay informed with the latest world news only on News18. Download the News18 App to stay updated! view comments First Published: July 10, 2025, 03:07 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
&w=3840&q=100)

Business Standard
14 minutes ago
- Business Standard
Best of BS Opinion: India's growth story needs harmony, not exits
There are some mornings when you catch a group of teens with mismatched instruments rehearsing in the park. An off-key trumpet, a scratched-up guitar, and sometimes one hesitant drummer. It sounds like noise at first. But wait a few minutes and suddenly, the pieces fall in place. The rhythm kicks in, the melody gels, and something real begins. Not perfect, but promising. That's when the choice appears: sharpen the sound, perfect the sync, or walk away. Let's dive in. India faces that very choice across vastly different stages. The ASEAN Free Trade Agreement which came into force in 2010 and is currently under review, might seem like a discordant alliance to some. Domestic lobbies want out, citing dumped Chinese goods and lagging farm exports. But as our first editorial argues, that's like quitting the band when your mic isn't loud enough. Instead, India should fine-tune the rules, harmonise better with the region, and use the pact as a strategic amplifier in the Indo-Pacific. Then there's the Gini index, a stat that suggests India is one of the world's most equal countries. Cue the applause? Not quite. As our second editorial explains, consumption-based metrics mask deep distortions. Behind the curtain, rural-urban divides blare on like untuned basslines, and state-by-state income variations clash like overlapping tempos. To fix the score, India must orchestrate policies that bridge regions and generate inclusive growth before the dissonance drowns the melody. M Govinda Rao shows Karnataka as a cautionary concert. Bengaluru leads with unicorns and tech gigs, while North Karnataka stays muted, underfed and overlooked. Historical baggage, lopsided investment, and uneven governance have turned one state into two different playlists. It's time policymakers re-tune subsidies and capital flows, and let every region play its own solo. Meanwhile, Ajay Kumar's column on undersea cables reminds us that even backstage tech can make or break a performance. These digital lifelines, vital for India's data-heavy future, are exposed to sabotage and surveillance. Without tighter laws, more repair ships, and Quad-aligned strategy, India's internet symphony risks being cut mid-note. And Devangshu Datta's review of Commanded by Destiny: A General's Rise from Soldier to Statesman by General S M Shrinagesh brings us back to the roots: a soldier-statesman's memoir that echoes with history's crescendos and silent interludes. It's a reminder that enduring legacy, like good music, requires discipline, foresight and knowing when to let each instrument lead. Stay tuned, and remember, because the band's off-sync, don't quit on the song. Just rehearse harder!


India.com
15 minutes ago
- India.com
India's Pharma War Zone: How Delhi's Bulk Drug Push Is Rattling China
New Delhi: The heat is rising in India's pharmaceutical backrooms. Quiet factories. Long shifts. New chemical reactors humming across Himachal, Gujarat and Telangana. Something has shifted. China, long the uncontested supplier of India's drug ingredients, is suddenly nervous. Its prices are falling. Fast. Some slashed by 50%. This is no coincidence. The trigger? India's Rs 6,940 crore Production-Linked Incentive (PLI) scheme. Launched in March 2020, it was a shot across the bow. And the target: reduce dependence on Chinese Active Pharmaceutical Ingredients (APIs). By December 2024, 48 domestic API projects were sanctioned. Of these, 34 are already operational. Together, they cover 25 key drug molecules. The investment so far? Rs 4,254 crore. But the Chinese are not backing down quietly. They are throwing prices into free fall. Landed costs of certain APIs from China have collapsed far deeper than Indian prices. Take Atorvastatin, used in cholesterol pills, for instance. Indian API prices fell 17% to Rs 10,000 per kg. China pushed it down to Rs 8,000 per kg. That is a 33% crash. Let's understand with another example of Ofloxacin, a broad-spectrum antibiotic. Indian prices dropped from Rs 3,200 to Rs 2,700. China? Rs 2,100. Down 30% in a year. This is price war, not coincidence. Bhavin Mukund Mehta, director of the Kilitch Drugs and Vice Chairman of Pharmexcil, minced no words, 'Even though the PLI has helped reduce the prices of domestically-produced APIs, the Chinese players are undercutting the competition in specific product categories to retain their market share.' Behind the scenes, policymakers are reviewing the PLI's next phase. They are asked industry insiders for help. The mission is to stop China's dumping spree, push for stronger local production and close the gaping supply chain hole exposed during COVID. The Department of Pharmaceuticals is now asking – can India stand on its own chemical legs and can it stop the bleed from Beijing's pricing games? The pressure is on. China still supplies around 70% of India's API imports. India imports about 50% of its total bulk drug needs. That is the strategic choke point the PLI is aiming to break. The scheme covers the production period from FY23 to FY29. But the impact is already being felt. Jatish Sheth, secretary general of the Confederation of Indian Pharmaceutical Industry, sees this as China's last stand. 'It is an expected move from the Chinese exporters to bring down the bulk drugs prices. While their focus is to retain the market share, we believe that this is a temporary phenomenon. We do not expect the Chinese players to keep selling the drugs at such low prices for too long.' He is betting on patience. Indian drugmakers are playing the long game. With new infrastructure, newer molecules and tighter government support, the tide could soon turn. But for now, it is a staring contest across lab benches and import docks. On one side, old Chinese dominance. On the other, rising Indian ambition backed by billions. And in between? A market worth tens of billions and the chemical backbone of the world's pharmacy.